Marc Vogel

2.1k total citations
100 papers, 1.1k citations indexed

About

Marc Vogel is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Pharmacology. According to data from OpenAlex, Marc Vogel has authored 100 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Public Health, Environmental and Occupational Health, 30 papers in Epidemiology and 21 papers in Pharmacology. Recurrent topics in Marc Vogel's work include Opioid Use Disorder Treatment (38 papers), Substance Abuse Treatment and Outcomes (25 papers) and Cannabis and Cannabinoid Research (15 papers). Marc Vogel is often cited by papers focused on Opioid Use Disorder Treatment (38 papers), Substance Abuse Treatment and Outcomes (25 papers) and Cannabis and Cannabinoid Research (15 papers). Marc Vogel collaborates with scholars based in Switzerland, Canada and Germany. Marc Vogel's co-authors include Marc Walter, Kenneth M. Dürsteler, Johannes Strasser, Gerhard A. Wiesbeck, Kenneth M. Dürsteler‐MacFarland, Undine E. Lang, Stefan Borgwardt, U. von Bardeleben, Robert Hämmig and Sylvie Petitjean and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Clinical Epidemiology.

In The Last Decade

Marc Vogel

94 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Vogel Switzerland 18 492 330 196 173 166 100 1.1k
Lisham Ashrafioun United States 21 372 0.8× 270 0.8× 506 2.6× 222 1.3× 122 0.7× 71 1.2k
Annie Mino Switzerland 12 330 0.7× 326 1.0× 112 0.6× 112 0.6× 72 0.4× 14 855
Kenneth M. Dürsteler Switzerland 15 295 0.6× 158 0.5× 152 0.8× 100 0.6× 111 0.7× 57 708
Shalini Arunogiri Australia 13 299 0.6× 318 1.0× 312 1.6× 136 0.8× 62 0.4× 74 940
Thomas Kosten United States 17 367 0.7× 371 1.1× 166 0.8× 189 1.1× 77 0.5× 29 1.1k
Joan Trujols Spain 21 383 0.8× 450 1.4× 375 1.9× 170 1.0× 65 0.4× 86 1.4k
Claudio Leonardi Italy 20 274 0.6× 280 0.8× 189 1.0× 148 0.9× 101 0.6× 66 938
Gabriele Koller Germany 15 249 0.5× 254 0.8× 140 0.7× 195 1.1× 39 0.2× 41 803
John A. Renner United States 14 993 2.0× 808 2.4× 126 0.6× 209 1.2× 153 0.9× 35 1.6k
R. Jeffrey Goldsmith United States 16 438 0.9× 571 1.7× 122 0.6× 170 1.0× 80 0.5× 32 1.1k

Countries citing papers authored by Marc Vogel

Since Specialization
Citations

This map shows the geographic impact of Marc Vogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Vogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Vogel more than expected).

Fields of papers citing papers by Marc Vogel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Vogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Vogel. The network helps show where Marc Vogel may publish in the future.

Co-authorship network of co-authors of Marc Vogel

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Vogel. A scholar is included among the top collaborators of Marc Vogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Vogel. Marc Vogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Westenberg, Jean N., Christian Appenzeller‐Herzog, Marco Cattaneo, et al.. (2025). Relative risks of adverse effects across different opioid agonist treatments—A systematic review and meta‐analysis. Addiction. 120(6). 1112–1126. 4 indexed citations
2.
Liwinski, Timur, R. Gaupp, Annette Beatrix Brühl, et al.. (2025). Patient Perspectives on Open-Door Policies in Psychiatry: Mixed Methods Study. Journal of Medical Internet Research. 27. e73610–e73610.
3.
Vogel, Marc, et al.. (2023). Effects of cannabis regulation in Switzerland: Study protocol of a randomized controlled trial. Frontiers in Psychiatry. 14. 1139325–1139325. 7 indexed citations
4.
Nikoo, Mohammadali, Fiona Choi, Marc Vogel, et al.. (2022). Opium tincture versus methadone for opioid agonist treatment: a randomized controlled trial. Addiction. 118(2). 284–294. 4 indexed citations
5.
Azar, Pouya, James S.H. Wong, Nickie Mathew, et al.. (2022). 48-hour Induction of Transdermal Buprenorphine to Sublingual Buprenorphine/Naloxone: The IPPAS Method. Journal of Addiction Medicine. 17(2). 233–236. 5 indexed citations
6.
Schaub, Anna-Chiara, Marc Vogel, Undine E. Lang, et al.. (2022). Striatal resting-state connectivity after long-term diacetylmorphine treatment in opioid-dependent patients. Brain Communications. 4(6). fcac275–fcac275. 2 indexed citations
7.
Dürsteler, Kenneth M., et al.. (2022). Co-occurring Mental Disorders in Transitional Aged Youth With Substance Use Disorders – A Narrative Review. Frontiers in Psychiatry. 13. 827658–827658. 14 indexed citations
8.
9.
Busch, Martin, Charlotte Klein, Alfred Uhl, et al.. (2021). Retention in the Austrian opioid agonist treatment system: a national prospective cohort study. Harm Reduction Journal. 18(1). 25–25. 8 indexed citations
10.
Krausz, Michael, Jean N. Westenberg, Nickie Mathew, et al.. (2021). Shifting North American drug markets and challenges for the system of care. International Journal of Mental Health Systems. 15(1). 86–86. 16 indexed citations
11.
Strasser, Johannes, et al.. (2021). Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice. Frontiers in Psychiatry. 11. 540837–540837. 16 indexed citations
12.
Nikoo, Mohammadali, Ehsan Moazen‐Zadeh, Alireza Kazemi, et al.. (2019). Comparing opium tincture and methadone for medication‐assisted treatment of patients with opioid use disorder: Protocol for a multicenter parallel group noninferiority double‐blind randomized controlled trial. International Journal of Methods in Psychiatric Research. 28(1). e1768–e1768. 13 indexed citations
13.
Colledge, Flora, et al.. (2017). A pilot randomized trial of exercise as adjunct therapy in a heroin-assisted treatment setting. Journal of Substance Abuse Treatment. 76. 49–57. 35 indexed citations
14.
Feng, Tom, et al.. (2016). The Impact of Smoking on Urologic Outcomes. 1(3). 1 indexed citations
15.
Vogel, Marc, Robert Hämmig, Johannes Strasser, et al.. (2016). Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the “Bernese method”. Dove Medical Press (Taylor and Francis Group). Volume 7. 99–105. 149 indexed citations
16.
Vogel, Marc, Patricia Bucher, Johannes Strasser, et al.. (2016). Similar and Different? Subjective Effects of Methylphenidate and Cocaine in Opioid-Maintained Patients. Journal of Psychoactive Drugs. 48(2). 93–100. 11 indexed citations
17.
Nordt, Carlos, Marc Vogel, Kenneth M. Dürsteler, Rudolf Stohler, & Marcus Herdener. (2015). A comprehensive model of treatment participation in chronic disease allowed prediction of opioid substitution treatment participation in Zurich, 1992–2012. Journal of Clinical Epidemiology. 68(11). 1346–1354. 13 indexed citations
18.
Seifert, Christian, Stefano Magon, Till Sprenger, et al.. (2014). Reduced volume of the nucleus accumbens in heroin addiction. European Archives of Psychiatry and Clinical Neuroscience. 265(8). 637–645. 59 indexed citations
19.
Vogel, Marc, et al.. (2012). Cost of attempted suicide: a retrospective study of extent and associated factors. Swiss Medical Weekly. 142(2930). w13648–w13648. 28 indexed citations
20.
Nübling, Damaris & Marc Vogel. (2004). Fluchen und Schimpfen kontrastiv. Zur sexuellen, krankheitsbasierten, skatologischen und religiösen Fluch- und Schimpfwortprototypik im Niederländischen, Deutschen und Schwedischen. Data Archiving and Networked Services (DANS). 59. 19–33. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisham Ashrafioun Breakdown of academic impact, for papers by Annie Mino Breakdown of academic impact, for papers by Kenneth M. Dürsteler Breakdown of academic impact, for papers by Shalini Arunogiri Breakdown of academic impact, for papers by Thomas Kosten Breakdown of academic impact, for papers by Joan Trujols Breakdown of academic impact, for papers by Claudio Leonardi Breakdown of academic impact, for papers by Gabriele Koller Breakdown of academic impact, for papers by John A. Renner Breakdown of academic impact, for papers by R. Jeffrey Goldsmith
Rankless by CCL
2026